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The microbiota-gut-brain axis encompasses a bidirectional mode of communication between 
the microorganisms residing in our gut, and our brain function and behavior. The composition 
of the gut microbiota is subject to diurnal variation and is entrained by host circadian rhythms. 
In turn, a diverse microbiota is essential for optimal regulation of host circadian pathways. 
Disruption of the cyclical nature of this microbe-host interaction profoundly influences disease 
pathology and severity. This review aims to summarize current knowledge on this bidirectional 
relationship. Indeed the past few years have revealed promising data regarding the relationship 
between the microbiota-gut-brain axis and circadian rhythms and how they act in concert to 
influence disease, further research needs to be done to examine how they coalesce to 
modulate severity of, and risk for, certain diseases. Moreover, there is a need for a greater 







The Human Microbiome 
The human body exists in a constant, mutualistic relationship with a sizeable community of 
microorganisms known as the human microbiota (Lynch and Pedersen, 2016, Gilbert et al., 
2018). Because of recent technological advances we are now able to study these trillions of 
microorganisms in greater detail than ever before, improving our understanding of the 
microbiota (the microorganisms themselves), the microbiome (the collective genetic material of 
all the microorganisms in and on the human body), and the environment in which they reside 
(Lynch and Pedersen, 2016, Gilbert et al., 2018). The highest concentration of our microbiota 
inhabit the human gastrointestinal tract, where they are responsible for dietary and xenobiotic 
compound metabolism (Cho and Blaser, 2012, Cryan et al., 2019a, Clarke et al., 2019). The two 
dominant groups of symbiotic bacteria found in the human gut are Bacteroidetes and 
Firmicutes, representing over 99% of the known gut microbiota (Ley et al., 2006, Maier et al., 
2017) and alterations in their relative abundance has been associated with disorders such as 
obesity (Ley et al., 2006). Analyses of the microbiota composition of human subjects, combined 
with studies in antibiotic-treated or germ-free rodents, are beginning to uncover the functional 
contribution of the microbiota to the health of the mammalian host (Cho and Blaser, 2012, 
Franklin and Ericsson, 2017). It is important to note however, studies have not been able to 
identify a specific bacterial genus or species and attribute it to a disease state or physiological 
system. Instead, studies can state that the microbiota of one experimental group is different 
from a control group, or correlate certain bacterial classifications to these disease states or 
physiological systems. Even when a certain bacterial genus or species is associated with a 
disease, this observation is usually only correlative (Marin et al., 2017). Perturbation of the gut 
microbiota is associated with a growing list of diseases from gastrointestinal disorders such as 
inflammatory bowel disease (Zuo and Ng, 2018) to metabolic disorders (Wen et al., 2008, 
Turnbaugh et al., 2008). More recently, the concept of a microbiota-gut-brain axis (the 
bidirectional communication pathway between our brain and the microbiome in our gut) has 
emerged with implications for the gut microbiota involvement in psychiatric and neurological  
disorders including autism spectrum disorder, Alzheimer’s disease, Parkinson’s disease, and 
depression (Rhee et al., 2009, Bernstein, 2017, Cryan et al., 2019b, Tansey, 2019). 
 
The Microbiota-Gut-Brain-Axis 
Consideration of the microbiota-gut-brain axis has revolutionized how neuroscientists view the 
brain and behavior, and neural disease (Rhee et al., 2009, De Palma et al., 2014, Cryan et al., 
2019a). There are multiple direct and indirect pathways through which the gut and brain 
communicate: the vagus nerve (Bonaz et al., 2018, Fulling et al., 2019), neuroactive monoamine 
neuromodulators (Liu et al., 2016, Valles-Colomer et al., 2019), the immune system (Cho and 
Blaser, 2012, Codagnone et al., 2019), the endocrine system (Farzi et al., 2018, Cussotto et al., 
2018) and via microbial metabolites such as short-chain fatty acids (SCFAs, (van de Wouw et al., 
2018, Liu et al., 2019b)) and bile acids (Wahlstrom et al., 2016, MahmoudianDehkordi et al., 
2019). It is becoming clear that age, diet, and health and disease all differentially influence 
microbiome to brain signaling (Rhee et al., 2009, De Palma et al., 2014, Borre et al., 2014, Cryan 
et al., 2019a). 
 
Our microbiota synthesize neurotransmitters such as γ‐amino butyric acid (GABA), 
noradrenaline, and dopamine, in the gut (Lyte, 2014, Strandwitz et al., 2019), which is a 
potentially significant avenue of communication between the gut microbiota and their host. 
Neuroactive bacterial metabolites can modulate brain function and host behavior through a 
myriad of ways that are still being elucidated (Clarke et al., 2019). Known methods include 
interacting with gut epithelial cells altering gut barrier function (Allaire et al., 2018), activating 
enteroendocrine cells to stimulate the release of gut hormones (Latorre et al., 2016), and 
modulation of dendritic cells altering immune and microglial function (Lin and Zhang, 2017). To 
date however, the mechanisms involved remain to be defined.  
 
Often, age-related diseases have a signature in the gut microbiota that has been shown to 
correlate with brain health (Cattaneo et al., 2017, Codagnone et al., 2019). Notably, birth mode 
(caesarean section or vaginal delivery) influences the composition of the early gut microbiota, 
which in turn may affect the brain and behavior (Dinan and Cryan, 2017b, Stinson et al., 2018, 
Montoya-Williams et al., 2018). Eating behaviors and diets can also have a significant influence 
on the gut microbiota population (Zarrinpar et al., 2014, Leitao-Goncalves et al., 2017, Ma et 
al., 2018, Singh et al., 2017). For instance, a high-fiber diet has been associated with enhancing 
the abundance of Lactobacillus, Bifidobacterium, and Faecalibacterium, which in turn have 
been positively associated with brain health, in particular demonstrating protection against 
psychiatric disorders (Heinritz et al., 2016, Baxter et al., 2019, Li et al., 2016). Conversely, a 
high-fat, obesity-inducing diet is strongly associated with an overgrowth in endotoxin-
producing pathogens of the Enterobacter genus, including Escherichia coli (Fei and Zhao, 2013). 
Interestingly, such psychiatric disorders (Leone et al., 2015, Thaiss et al., 2014) and metabolic 
disorders such as obesity (Leone et al., 2015, Thaiss et al., 2014) have also been linked to 
circadian rhythms. In fact, due to the strong overlap of diseases related to the gut microbiota 
and physiological circadian cycles, researchers have begun to examine the interactions between 
the microbiota-gut-brain axis and circadian rhythmicity (Voigt et al., 2016a, Parkar et al., 2019, 
Tahara et al., 2018, Deaver et al., 2018). 
 
Circadian Rhythms 
Circadian rhythms are present in the majority of organisms, and synchronize important 
physiological activities at every level of organization in the body: from rest-wake timing to 
cellular-level metabolic processes (Scheiermann et al., 2013, Voigt et al., 2016a, Sollars and 
Pickard, 2015, Weger et al., 2019). The mammalian circadian clock follows an approximately 24-
hour feedback loop of transcription and translation as described in Figure 1 (Voigt et al., 2016a, 
Takahashi, 2017). The endogenous biological clock relies on zeitgebers, or environmental cues 
such as light (the primary zeitgeber), food timing, food type, exercise, temperature, and 
infection to keep the circadian clock synchronized with the environment (Tognini et al., 2017, 
Takahashi, 2017). The central circadian clock is located in the suprachiasmatic nucleus (SCN) of 
the hypothalamus, which receives innervation from the retinohypothalamic tract (Brown, 
1994). The SCN master clock can be reset by light (Wu et al., 2018a) and light-dark cycles. It is 
enhanced through a positive feedback loop with melatonin, a key hormone in sleep and 
circadian rhythmicity (Brown, 1994).  
 
The SCN acts as the organizational hub of host circadian rhythms and regulates circadian 
pathways in peripheral tissues (peripheral clocks) via nerve impulses and hormones (Sollars and 
Pickard, 2015, Voigt et al., 2013). Most tissues in the human body express the same circadian 
rhythm genes and proteins as the SCN and have autonomous biological clocks that are linked to 
diurnal regulation of physiological functions. Approximately 5-10% of the genes in peripheral 
tissue are regulated by circadian oscillations (Sollars and Pickard, 2015). Therefore, 
synchronization of these peripheral circadian oscillations by the SCN is crucial to coordinate the 
operation of cells, tissues, organs and organisms in processes such as immune function, body 
temperature, blood pressure, energy allocation, metabolism, absorption of nutrients, insulin 
levels, and hormone secretion (Voigt et al., 2013, Potter et al., 2016). Different organisms have 
different circadian responses to the light-dark cycle; humans are diurnal, or active during the 
day (in response to light), and rodents are nocturnal, or active at night (in response to a lack of 
light). Indeed gut microbiome composition, sleep physiology, the immune system and cognition 
appear to have common linkages (Smith et al., 2019). 
 
Many factors can disrupt the circadian rhythm, including environmental insults, gene 
polymorphisms, or behavior. Current social expectations impose negative environmental 
factors on circadian rhythm such as jet lag (Reid and Abbott, 2015, Inder et al., 2016), shift work 
(Reid and Abbott, 2015, Schilperoort et al., 2019), social jetlag (Roenneberg et al., 2012, 
Roenneberg et al., 2019), light or food at night (Burgess and Molina, 2014, Asher and Sassone-
Corsi, 2015), inconsistent eating times (Asher and Sassone-Corsi, 2015, Tahara et al., 2018), and 
the “western” high-fat diet (Kohsaka et al., 2007, Leone et al., 2015). Many studies have 
examined circadian disruption in mice with knockouts or polymorphisms of genes involved in or 
related to the circadian cycle (Liang et al., 2015, Thaiss et al., 2014, Voigt et al., 2016b, 
Mazzoccoli et al., 2012, Patke et al., 2017).  
 
Recent evidence also identifies the microbiota as both modulated by, and a modulator of, the 
central and peripheral clocks (Leone et al., 2015, Liang et al., 2015, Thaiss et al., 2014, Zarrinpar 
et al., 2014, Voigt et al., 2014, Voigt et al., 2016b, Mukherji et al., 2013, Thaiss et al., 2016). 
Altered circadian rhythms, irrespective of cause, have been implicated in a multitude of 
diseases including metabolic diseases such as obesity (Turek et al., 2005, Froy and Garaulet, 
2018), sleep disorders (Patke et al., 2017, Ma et al., 2019), psychiatric disorders such as bipolar 
illness (Benedetti et al., 2003, Takaesu, 2018), and neurodegenerative diseases such as 
Alzheimer’s disease (Canevelli et al., 2016, Song et al., 2015). 
 
Thus, given the influence of both the microbiota-gut-brain axis and circadian rhythms in host 
physiological processes, it is crucial to study the interplay between these two systems in health 
and disease (Figure 1A). The involvement of circadian rhythms on the microbiota-gut-brain axis 
and vice versa calls into question the potential mechanisms involved. Many studies implicate 
dysfunction as either instigators or enhancers of metabolic or endocrine disease, inflammation, 
and negative behavioral changes. This review will explore the relationship between circadian 
rhythms and the microbiota-gut-brain axis, and examine metabolic, endocrine, and immune 
nodes of interaction particularly in the context of different diseases in which these two systems 
are implicated.  
 
Bacterial Circadian Rhythm and Microbiota Compositional Oscillations 
One of the earliest reported observations of a bacterial circadian rhythm was witnessed in a 
cyanobacteria in 1986 (Grobbelaar et al., 1986). More recently, it was reported that the 
swarming pattern of the human gut bacterium Enterobacter aerogenes, followed an 
endogenous circadian rhythm that was entrained by melatonin to a periodicity of 25.1 ± 1.4 
hours (Table 3A (Paulose et al., 2016)). In another example of microbe-host symbiosis, the 
circadian-controlled luminosity of the symbiotic bacterium Vibrio fischeri was shown to regulate 
diurnal gene transcription in its host squid species, Euprymna scolopes (Heath-Heckman et al., 
2013).  
 
An extensive number of gut bacterial genera and species, as well as the microbial community as 
a whole, exhibit oscillatory behavior (Table 3) in response to both the time of day (Leone et al., 
2015, Liang et al., 2015, Thaiss et al., 2014, Zarrinpar et al., 2014, Kaczmarek et al., 2017), and 
time of eating (Leone et al., 2015, Liang et al., 2015, Thaiss et al., 2014, Zarrinpar et al., 2014, 
Kaczmarek et al., 2017). Approximately 35% of the measured bacterial operational taxonomic 
units (OTUs) in humans undergo temporal rhythmicity, and these diurnal gut microbiota 
oscillations have also been found across multiple studies of human (Kaczmarek et al., 2017, 
Thaiss et al., 2014) and rodent gut microbiota (Leone et al., 2015, Liang et al., 2015, Thaiss et 
al., 2014, Zarrinpar et al., 2014). The microbial community composition and abundance also 
fluctuate as a function of time; the bacterial load in mice reaches a peak at 11 PM (active phase 
in nocturnal organisms), corresponding with a maximum in the Bacteriodetes population, and 
reaches a trough at 7 AM (rest phase) corresponding with a maximum in the Firmicutes 
population (Leone et al., 2015, Liang et al., 2015, Zarrinpar et al., 2014). However, it is perhaps 
surprising that such examples of bacterial circadian rhythm and microbiota compositional 
oscillations have yet to be studied in the context of brain health and cognitive function.  
 
Effect of Host Circadian Rhythmicity on Gut Microbiota  
Dysregulation of the microbiota host’s circadian rhythm can significantly affect microbial 
oscillations (Figure 2). Preclinical examples include deleted circadian clock genes in mice (Thaiss 
et al., 2014, Voigt et al., 2014), the timing or restriction of food availability (Thaiss et al., 2014, 
Voigt et al., 2014), and light: dark phase change, or reversal in mice to examine the effect of jet 
lag and shift work in humans (Figure 2, Figure 3 (Thaiss et al., 2014, Voigt et al., 2014).  
 
Genetic Models of Circadian Circuit Modulation  
Many studies have examined the effect of aberrant circadian clock genes on physiological 
functions and rhythmic activity in the body. Bmal1 and Per1/2-/- knockout (KO) mice experience 
a significant reduction or ablation of gut microbiota diurnal oscillations compared to wild-type 
mice (Liang et al., 2015, Thaiss et al., 2014, Pagel et al., 2017), which also ablated circadian 
rhythm behavior of the fecal microbiota (Liang et al., 2015), increased susceptibility to intestinal 
inflammation manifested as IBD (Pagel et al., 2017), and resulted in an aberrant microbial 
diurnal rhythm, driven by a disrupted feeding rhythmicity, as well as glucose intolerance and 
obesity (Thaiss et al., 2014). In Bmal1 KO mice, this decrease in gut microbiota diurnal 
oscillations is associated with a complete eradication of diurnal oscillations in Bacteriodetes and 
Firmicutes compared to wild-type mice. Clock∆19 mice (dominant homozygous for the ∆19 allele, 
leading to a lengthened endogenous period and a loss of rhythmicity) have a less diverse gut 
microbiota than wild-type mice when fed a control diet, and a different microbial community 
structure when fed a high-fat diet (Voigt et al., 2014, King et al., 1997). Together, these 
experiments demonstrate that deficiencies in biological clock genes cause negative 
perturbations of the gut microbiota, independent of, but influenced by, diet. Interestingly, this 
change in the gut microbiota can be rescued by food restriction or timing (Thaiss et al., 2014).  
 
Timed and Restricted Feeding 
It has been shown that both timed feeding, or restriction of feeding, can induce drastic changes 
to the rhythmicity of the gut microbiota. Although Per1/2-/- mice fed ad libitum lack gut 
microbial diurnal rhythmicity, when fed on a schedule, they exhibit restored gut microbiota 
diurnal oscillations (Thaiss et al., 2014). Lean mice fed ad libitum showed strong microbial 
diurnal rhythmicity, which was abolished following a high-fat diet; however, when the mice 
were fed a time-restricted high-fat diet, they still maintained some gut microbiota diurnal 
rhythmicity and a lean phenotype (Zarrinpar et al., 2014). Mice on a high-fat diet that 
underwent intermittent fasting – a positive restriction of food timing – exhibited an altered gut 
microbiota and decrease in obesity only present when the microbiota was present, thus not 
seen in germ-free mice (Li et al., 2017).  
 
Abnormal Light-Dark Cycle 
Many studies alter the light-dark cycle to examine its effect on circadian rhythmicity, using 
either a phase shift (Thaiss et al., 2014, Schilperoort et al., 2019), a 24-hour light (Deaver et al., 
2018), or a 24-hour dark paradigm (Wu et al., 2018a). Animals housed under either 24-hour 
conditions, combined with standard feeding, lost all gut microbial diurnal rhythmicity when 
compared to mice housed under normal conditions; the mice housed under a 24-hour dark 
cycle also manifested increased Clostridia abundance (Wu et al., 2018a, Deaver et al., 2018).  
 
Both jet lag and shift work have been associated with a wide variety of metabolic, 
inflammatory, and stress-related diseases (Khalyfa et al., 2017, Scheer et al., 2009, Karatsoreos, 
2014, Guerrero-Vargas et al., 2015, Inder et al., 2016).  
 
High-fat diet-fed mice that underwent a light: dark phase reversal paradigm representative of 
shift worked, exhibited a change in their gut microbiota population and a reduced microbial 
diversity compared their counterparts (Table 2A (Voigt et al., 2014)). Standard-chow-fed mice 
that underwent a phase-shift paradigm representative of jet lag (8-hour shift) incurred a loss of 
both diurnal rhythmicity in their gut microbiota and oscillating OTUs (Thaiss et al., 2014). 
Furthermore, the jet lag paradigm also exacerbated the effect of a high-fat diet in mice, namely 
increased weight gain and glucose intolerance. These results were corroborated in a human 
study during which two subjects underwent 8-10 hour flights to incur jet lag (Table 2A (Thaiss 
et al., 2014)). Their stool, 24 hours post-flight, encompassed a significantly altered microbiota 
composition characterized by a relative increase in Firmicutes compared to baseline and at 
recovery two weeks later (Thaiss et al., 2014).  
 
It is becoming apparent that alterations in host circadian rhythmicity have a profound effect on 
our gut microbiota, potentially leading to a feedback mechanism of gut microbial modulation of 
further circadian rhythm-dependent activity. This avenue of communication needs much more 
investigation at both the preclinical and clinical levels to help elucidate potential therapeutic 
interventional strategies.  
Effect of Gut Microbiota and its Metabolites on Host Circadian 
Rhythms 
Much research has examined the impact of the gut microbiota and its metabolites on host 
circadian rhythm (Figure 2). Initial research queried how a change in the microbiota could affect 
peripheral circadian clocks, as well as the effect of microbiota-derived metabolites or diet-
induced microbial changes may have on circadian clocks (Leone et al., 2015, Thaiss et al., 2016, 
Murakami et al., 2016, Govindarajan et al., 2016, Mukherji et al., 2013, Montagner et al., 2016).  
 
Altered Peripheral and Gut Clocks due to Gut Microbiota Perturbation 
Both germ-free and antibiotic-treated mice experience an alteration of their peripheral and gut 
clocks (Weger et al., 2019). Germ-free mice have significantly different mRNA expression of 
core circadian clock genes in the liver (Bmal1, Per1, Per2, and Cry1) compared to specific 
pathogen-free mice (Montagner et al., 2016). Furthermore, mice treated with antibiotics to 
ablate their gut microbiota had significantly altered levels of clock genes in the gut and 
periphery as well as a loss of rhythmicity of gut metabolites compared to wild-type mice 
(Mukherji et al., 2013, Thaiss et al., 2016). However, there are conflicting reports regarding the 
effect of antibiotic treatment on the expression of the core circadian clock genes in mice. 
Although one study (Mukherji et al., 2013) found that antibiotic-treated mice exhibited 
transcript-level changes in these genes, another (Thaiss et al., 2016) found that the oscillations 
of the core clock genes and their transcripts were independent of antibiotic-induced changes in 
the gut microbiota. These differences could be a result of methodological disparities between 
the studies; e.g. different cocktails of antibiotics for different lengths of time were used, and 
gut samples were prepared and stored differently (Mukherji et al., 2013, Thaiss et al., 2016). 
 
Effect of Microbiota-Derived Metabolites and SCFAs on the Circadian Clock 
Gut microbiota-derived metabolites including SCFAs (propionate, butyrate, acetate) and bile 
acids also alter circadian rhythms. For instance, not only do multiple bacterial metabolites 
oscillate, but the presence of the microbiota is crucial for metabolite rhythmicity, as germ-free 
and antibiotic-treated mice produce metabolites that do not oscillate diurnally (Thaiss et al., 
2016). Intriguingly, removal of polyamines from the murine diet influenced an aberrant 
expression pattern in hundreds of circadian genes, resulting in an expression profile, which 
resembled that seen with antibiotic-treated mice (Thaiss et al., 2016). They conclude that diet 
and the microbiota influence one another – the microbiota is necessary for rhythmicity of 
polyamines, and the absence of polyamines in the diet leads to a rhythmic pattern of circadian 
gene expression that is reminiscent of a depleted microbiota.  
 
Oral administration of SCFAs and lactate to antibiotic-treated mice changed PER2 rhythms 
transiently in peripheral tissue (Tahara et al., 2018). The introduction of SCFAs such as butyrate 
or acetate in vitro to hepatic organoids also led to significant phase shifts and increases in the 
amplitude of PER2 and BMAL1 rhythms (Leone et al., 2015). Other microbiota-related 
metabolites, such as unconjugated bile acids, have been shown to both upregulate circadian 
rhythm genes in an in vitro cellular model, and alter circadian clock gene expression (Arntl, 
Clock, Npas2, Per1,2,3, Cry1,2), as well as regulators of these genes (ROR, Nr1d1, Dbp, E4BP4) 
in the mouse ileum, colon and liver, when given orally (Govindarajan et al., 2016). Furthermore, 
jet-lagged mice that received this treatment at the beginning of their shifted dark phase 
underwent an accelerated entrainment of clock genes to light compared to jet-lagged control 
mice (Tahara et al., 2018). SCFAs are introduced naturally into the body, usually with a high-
fiber diet, which protects and encourages a healthy microbiota (Maslowski and Mackay, 2011, 
van de Wouw et al., 2018).  
 
Conversely, a high-fat diet has detrimental effects on the microbiota and the circadian clock 
(Leone et al., 2015). Specific-pathogen-free (SPF) mice fed a high-fat diet had increased 
expression of Bmal1 in the hypothalamus, and Per2 in the liver during the dark phase, whereas 
germ-free mice on a high-fat diet showed no change (Leone et al., 2015). Thus, diet alone was 
only capable of inducing host circadian rhythmicity alterations when paired with a functional 
gut microbiota. Furthermore, the high-fat diet also altered diurnal microbiota oscillations, 
which associated with a dysregulation of circadian clock rhythmicity (Leone et al., 2015, Thaiss 
et al., 2014). Interestingly, a high-fat diet given to mice lengthened the circadian period, 
decreased clock gene oscillation amplitudes, and de-synchronized liver and fat expression of 
clock gene-controlled transcription factors, when compared to a standard diet (Kohsaka et al., 
2007).  
 
Ad libitum access to a high-fat diet significantly affected host bile acid profiles in mice (Oh et al., 
2019). Specific bile acids impeded the activation of a circadian transcription factor and nuclear 
receptor peroxisome proliferator-activated receptor  (PPAR) that has been shown to mediate 
the relationship between a high-fat diet and resulting changes in hepatic oscillators (Kanemitsu 
et al., 2017, Murakami et al., 2016, Oh et al., 2019). Interestingly, mice fed a standard diet 
during their inactive period and mice fed a high-fat diet during their active period experienced 
similar changes in overall bile acid composition, indicating that both time of day and type of 
food consumed are important bile acid composition variables (Eggink et al., 2017). 
Furthermore, high-fat diet-fed mice subjected to timed feeding expressed higher levels of a 
principal ileal bile acid receptor farnesoid X receptor, with concomitantly reduced serum 
cholesterol levels compared to mice fed either a standard chow or a high-fat diet, ad libitum 
(Zarrinpar et al., 2014). The circadian-controlled signaling of bile acids through the farnesoid X 
receptor has also been linked to lipid metabolism. 
 
It is widely accepted that diet is one of the main avenues of gut microbiota modulation; 
therefore, it is understandable that diet would alter and interact with the gut microbiota in a 
profound manner, and in a cyclical fashion due to the nature of natural feeding patterns. It has 
become even more important to study these interactions in light of the circadian rhythm 
entrainment associated with feeding patterns, and more in-depth and carefully controlled 
research is warranted.  
Nodes of Interaction 
The microbiota-gut-brain axis and circadian rhythm interact with one another via multiple 
nodes and appear to work synergistically. This bidirectional interplay between the host 
circadian clocks and microbiota oscillations is undoubtedly key to the maintenance of host 
homeostasis. Here we consider how such an interplay affects key physiological processes in the 
host. 
Metabolism 
Organisms generally consume food during their active phase and fast during their inactive 
phase (Reinke and Asher, 2019). Food eaten at different times provide different amounts of 
glucose during the active phase; a meal in the evening produces a plasma glucose spike with 
twice the magnitude of the spike produced when the same meal is eaten for breakfast (Van 
Cauter et al., 1997). The time of day at which we eat also influences which microbes are active 
in the gut (Parkar et al., 2019, Van Cauter et al., 1997). Different microbial populations are 
subject to change based on food timing; certain bacterial groups will reach a population 
maximum when their energy source is available, whether it be directly when the food enters 
the gut or hours later where they attain energy from metabolized food. Interestingly, the α-
diversity (local species diversity) of the gut microbiota increases with feeding and decreases 
with fasting (Zarrinpar et al., 2014). The population of the gut microbiota further shows cyclical 
variation for different diets and feeding times, which is characterized by specific patterns of 
population fluctuation (Zarrinpar et al., 2014). For instance, mice fed a high-fat diet experienced 
a reduction in the Lactococcus genus (believed to be obesogenic) after they began time-
restricted feeding that was particularly noticeable during the inactive phase (Table 3B 
(Zarrinpar et al., 2014)). 
 
Interestingly, the presence of a gut microbiota has been found to directly regulate the 
expression of intestinal epithelial histone deacetylase 3 (HDAC3) (Table 1 (Kuang et al., 2019). 
The gut microbiota promotes diurnal oscillations of HDAC3, whereas the lack of a gut 
microbiota, as seen in germ-free mice, results in stably high HDAC3 levels. When HDAC3 
oscillates, it in turn rhythmically regulates histone acetylation, which regulates metabolic gene 
expression in a diurnally oscillatory manner (Kuang et al., 2019). Furthermore, the microbiota-
induced oscillations of HDAC3 are positively associated with lipid absorption and high-fat diet-
induced obesity via the lipid transporter gene Cd36, which is also regulated by Rev-erb, a key 
circadian clock gene (Kuang et al., 2019). 
 
Much work has focused on the interplay between circadian clock genes such as, ROR, Clock, 
Crys, Pers, Bmal1 and Rev-erb and metabolism (glucose, lipid and amino acid/protein) or 
metabolic dysfunction (obesity, cardiovascular disease, diabetes) (Adamovich et al., 2014, Dang 
et al., 2016, Yin et al., 2006, Wang et al., 2017, Shi et al., 2019). For instance, ROR knockout 
mutant mice (RORsg/sg) have an inactive ROR gene, and display decreased adiposity, serum 
high-density lipoprotein cholesterol levels and serum and liver triglyceride levels (Lau et al., 
2008). These mice are known as “staggerer” mice due to their uneven gait, imbalance and 
tremors, and display cerebellar defects (Lau et al., 2008). Furthermore, they did not gain weight 
when fed a high-fat diet compared to wild-type mice, demonstrating a role for ROR in fat 
accumulation (Table 2A (Lau et al., 2008)). However, these mice were more susceptible to 
atherosclerosis than wild-type mice, indicating ROR may play a protective role in 
atherosclerotic lesions (Lau et al., 2008). It is important to note that some of these phenotypes, 
such as the ROR, are quite severe, and caution exercised.  
 
Clock∆19/∆19 mutant mice also display smaller pancreatic islets, impaired insulin secretion, and 
decreased glucose tolerance (Marcheva et al., 2010), as well as hyperlipidemia, hyperglycemia, 
and hyperleptinemia (Table 2A (Turek et al., 2005)). The circadian gene Cry-1 has been shown 
to regulate gluconeogenesis via fasting-induced inhibition of CREB in mice (Zhang et al., 2010). 
In humans, the Cry1 mutation leads to a familial delayed sleep phase disorder, where 
individuals experience delayed sleep induction (Patke et al., 2017). Interestingly, a missense 
mutation in Per2 leads to a familial advanced sleep phase disorder (Fu et al., 2001). Per2-/- mice 
have changes in lipid metabolism and a decrease in both triglyceride and non-esterified fatty 
acid levels (Grimaldi et al., 2010). Interestingly, this relationship appears to be mediated by 
PPAR, and Per-2’s control of PPAR appears to be necessary in white adipose tissue for normal 
lipid metabolism (Grimaldi et al., 2010).  
 
Bmal1-/- mice exhibited increased plasma levels of adiponectin and leptin, increased adiposity, 
and increased glucose production (Kennaway et al., 2013). Rev-erb has also been shown to 
play a key role in adiposity; it represses an inhibitory pathway of brown adipocyte 
differentiation (Nam et al., 2015). Rev-erb -/- mice exhibit a strong impairment in brown fat 
formation (Nam et al., 2015). The gut microbiota also indirectly acts through Rev-erb to affect 
Nuclear Factor Interleukin 3 Regulator (NFIL3), which is a key regulator of lipid absorption and 
metabolism (Wang et al., 2017). When Rev-erb   is present, germ-free and antibiotic-treated 
mice have lower levels of NFIL3 than wild-type mice (Wang et al., 2017, Mukherji et al., 2013). 
In the absence of Rev-erb, there was no effect of the gut microbiota on NFIL3 expression or 
lipid metabolism.  
 
Although it is difficult to parse cause and effect elements of diet, feeding and microbial 
metabolite availability and their interaction with circadian mechanisms, and indeed several 
connections between modulators of the circadian rhythm and the gut microbiota are more 
distal connections and not necessarily causal, they may only constitute one mechanism of 
control amongst a plethora of systems at play. Therefore, it is critical for future studies to 
dissect out the relative contributions of these elements in both humans and model systems.  
 
The Endocrine System 
The microbiota-gut-brain axis and circadian rhythms often interact through the action of 
hormones. The SCN controls many of the endocrine glands both directly and indirectly 
(Bedrosian et al., 2016). Hormones secreted from these glands play a role in circadian 
rhythmicity and influence the gut microbiota, which can in turn influence the secretion of these 
hormones by feedback mechanisms (Bedrosian et al., 2016, Huo et al., 2017). 
 
The pineal gland secretes the hormone melatonin, which is an effector of, and effected by, 
circadian rhythmicity (Brown, 1994). Melatonin is crucial to diurnal rhythms, can entrain the 
circadian rhythms of some gut bacteria, and cause negative chemotaxis of bacteria such as 
Escherichia coli (Table 1 (Brown, 1994, Paulose et al., 2016, Lopes and Sourjik, 2018)). Directly 
innervated by the SCN, the paraventricular nucleus of the hypothalamus secretes the stress-
related hormone corticotropin-releasing factor (CRF), which stimulates the anterior pituitary 
gland to secrete adrenocorticotropic hormone (ACTH) (Bedrosian et al., 2016). Both hormones 
are key components of the hypothalamic-pituitary-adrenal axis (HPA axis), which regulates the 
body’s response to stress (among other duties). The HPA axis oscillates under the control of the 
circadian clock, which is affected by changes in the gut microbiota (Table 1 (Huo et al., 2017, 
Hoban et al., 2016, Shanks et al., 1995, Cussotto et al., 2018, Sudo et al., 2004)).  
 
The adrenal glands respond to ACTH release by secreting glucocorticoids (Luo et al., 
2018)(cortisol in humans, corticosterone in rodents), which are also key components of HPA 
axis activity (Bedrosian et al., 2016). Glucocorticoids act as a negative feedback messenger of 
this stress-response system and identify a link between circadian rhythms, the endocrine 
system, and the gut microbiota (Table 1 (Agusti et al., 2018, Sudo et al., 2004)). Glucocorticoids 
are often prescribed as immunosuppressant and anti-inflammatory drugs, yet they have severe 
metabolic and neurological side effects, such as increased lipid accumulation, decreased gut 
microbiota diversity, and disrupted circadian rhythmicity in both the SCN and periphery (Wu et 
al., 2018b). In addition, work performed with germ-free mice has shown that the lack of a gut 
microbiome can regulate glucocorticoid receptor genes in the hippocampus, indirectly 
regulating cognitive function including depression (Table 2 (Luo et al., 2018). However, it is 
important to note that the germ-free phenotype is severe, thus information gleaned from it 
should be regarded cautiously. 
 
A recent study (Table 1 (Weger et al., 2019)) found that growth hormone (key to sexual growth 
and dimorphism), testosterone (male-biased hormone), and estradiol (female-biased hormone) 
secretion were all altered in germ-free mice compared to wild types. The rhythmicity of these 
hormones that is typically present in wild-type mice, in a sex-biased manner, was abolished in 
germ-free mice, with blunted hormone levels (Weger et al., 2019). Furthermore, the secretion 
of ghrelin, a hormone upstream of growth hormone, was also reduced and non-rhythmic in 
germ-free mice (Weger et al., 2019). Ghrelin controls appetite and thus the timing of food, 
linking it with the gut microbiota (Lach et al., 2018). Serum ghrelin levels have been negatively 
associated with the amount of Bifidobacterium, Lactobacillus, and B. coccoides – Eubacterium 
rectale, and positively associated with the amount of Bacteroides and Prevotella in rats 
(Queipo-Ortuno et al., 2013). Ghrelin oscillates diurnally, is affected by alterations to the 
circadian clock, and can rescue circadian rhythm deficits induced by a high-fat diet in mice 
(Table 1 (Wang et al., 2018, Turek et al., 2005)). It has long been known that circadian rhythms 
and the SCN directly affect the endocrine system (Froy and Garaulet, 2018). Considering recent 
work describing the interaction between the endocrine system and the gut microbiota, this is of 
particular interest as it identifies the endocrine system as a node of interaction between 
circadian rhythms and the gut microbiota.  
 
The Immune System and Inflammation 
At birth, the formation of a well-functioning gut mucosal immune system depends on a healthy 
commensal bacterial population in the host’s gut (Dinan and Cryan, 2017a). As the child ages, 
the immune system’s interactions with the microbiota-gut-brain axis shifts toward an indicator 
of gut microbial stress. The majority of immune cells and cytokines oscillate diurnally 
(Labrecque and Cermakian, 2015, Keller et al., 2009), which affects how they respond to insults 
to their host, as well as immune cell population growth and activity, lymphocyte number and 
circulation, humoral response, macrophage transcriptome, and cytokine levels (Table 1 
(Labrecque and Cermakian, 2015, Keller et al., 2009)). Furthermore, phase-dependent 
responses have been seen in pathogen susceptibility, asthma, rheumatoid arthritis, and other 
autoimmune diseases (Keller et al., 2009, Labrecque and Cermakian, 2015). Studies have shown 
diurnal rhythmicity of both the expression of toll-like receptor 9 (TLR9) in response to bacterial 
or viral DNA (Labrecque and Cermakian, 2015, Silver et al., 2012), and the downstream signaling 
capacity of toll-like receptor 4 (TLR4) (Labrecque and Cermakian, 2015). Furthermore, TLR 
transcripts were lower in mice treated with antibiotics, and were directly associated with clock 
components (such as the binding of BMAL1 to the E box for TLR9) (Mukherji et al., 2013). Thus, 
TLR’s are key converters of bacterial signals into rhythmic gene expression.  
 
Neutrophils also exhibit circadian rhythmicity and are susceptible to gut microbiota 
perturbations (Table 1 (Adrover et al., 2019, Zhang et al., 2015)). In particular, neutrophil aging 
is associated with increased anti-microbial activity and resistance to infection. However, this is 
also associated with vascular inflammation and reduced cardiovascular health (Adrover et al., 
2019). T cells are also regulated by circadian rhythmicity and the gut microbiota (Table 1 
(Bollinger et al., 2011, Yu et al., 2013, Ren et al., 2017, Soto et al., 2017, Mazmanian et al., 
2005)). T-cells undergo NFIL3-mediated (and mostly REV-ERB-controlled) rhythmic 
development and differentiation from immature to mature T cells (Yu et al., 2013, Bollinger et 
al., 2011); mature T cells exhibit rhythmic production of cytokines (Yu et al., 2013, Bollinger et 
al., 2011). Furthermore, melatonin has been identified as a potent regulator of many types of T 
cells, including Th17, T regulatory cells, and memory T cells (Ren et al., 2017).  
 
The microbiota is also involved in maintenance of a functioning immune system, and T cell 
development and lifespan (Soto et al., 2017, Lee et al., 2011). In fact, the microbiota is involved 
in the development of Th1, Th2, Th17, and Treg cells (Lee et al., 2011). Considering the 
importance of the gut microbiota in the development of the immune system, it is not surprising 
that germ-free mice exhibit decreased efficiency of T cells, B cells and neutrophils, and 
decreased production of CD4+ T cells and antibodies (Belizario et al., 2018). Furthermore, the 
immune system is less effective in response to infection in germ-free mice (Table 1 (Belizario et 
al., 2018)). Since the 1960s, studies have also found a relationship between the time of day of 
an infection – e.g. from Escherichia coli, Streptococcus pneumoniae, and Salmonella enterica 
Serovar Typhimurium – and both the body’s immune response and infection colonization (Table 
1 (Halberg et al., 1960, Feigin et al., 1969, Bellet et al., 2013)). In fact, it has been hypothesized 
that inflammation may act as an intermediary between circadian rhythms, the gut microbiota, 
and these diseases (Voigt et al., 2016a). Additionally, negative changes in the gut microbiota or 
circadian rhythms are both associated with low-grade, sterile inflammation throughout the 
body, most likely due to a reduction of intestinal barrier integrity (Voigt et al., 2016a).  
 
With the densest collection of immune cells in the human body, the GI tract is a critical target 
for immune system modulation, inflammation, and its involvement in centrally mediated events 
such as circadian rhythm control. It is critical that future research efforts are focused on 
examining the role of gut inflammation and the immune system’s response to the gut 
microbiota in circadian rhythm control.  
 
The involvement of circadian rhythms and the microbiota-gut-brain 
axis in disease 
Metabolic Diseases 
Accumulating evidence suggests that metabolic disorders can arise from the interaction 
between high-fat diet and other factors, including both circadian rhythm disruption (Parkar et 
al., 2019) or changes in the composition of the gut microbiota (Table 2A (Zinocker and Lindseth, 
2018)). One large-scale study found that the gut microbiota of multiple metabolically-diseased 
populations (cardiovascular disease, type 2 diabetes, and obesity) had an increased 
inflammatory potential, meaning that the bacteria present in the microbiota of humans with 
these diseases are more likely to cause inflammation than the bacteria present in the 
microbiota of humans without the disease (Jie et al., 2017), suggesting a potential novel route 
of treatment. Mouse models of shift work (light/dark phase reversal) were associated with 
higher levels of HOMO-IR (a measure of insulin resistance), altered microbiota, increased gut 
permeability, and an increase in pro-inflammatory, and a decrease in anti-inflammatory 
immune cells (Khalyfa et al., 2017). This work suggests that both circadian rhythms and the gut 
microbiota could be mediators between a high-fat diet and metabolic disorders such as obesity, 
diabetes and cardiovascular disease. 
 
Obesity 
To date, the strongest link between circadian rhythms and the gut microbiota in disease has 
come from obesity research (Table 2A (Leone et al., 2015, Thaiss et al., 2014, Voigt et al., 
2016b, Joyce et al., 2014a, Li et al., 2017, Shao et al., 2018, Yin et al., 2018, Stenvers et al., 
2019, Froy and Garaulet, 2018)). The absence of a gut microbiota protects mice from the 
negative ramifications of a high-fat diet, and the induction of a circadian clock phase shift (in 
wild-type mice) exacerbates these negative ramifications (Leone et al., 2015, Thaiss et al., 
2014). Clock mutant mice demonstrate the effect of circadian clock disruption on the gut 
microbiota, and how this leads to metabolic dysfunction, such as obesity and diabetes (Voigt et 
al., 2016b, Turek et al., 2005). Interestingly, bile salt hydrolase (BSH), a key factor in lipid 
metabolism produced by certain bacteria in the gut, is a key mediator of the effect of a high-fat 
diet on obesity (Kanemitsu et al., 2017, Murakami et al., 2016). BSH is crucial for generating a 
diverse bile acid signature in the host, and its activity in the microbiota regulates host 
physiological processes including metabolism, circadian rhythmicity and immune response 
(Table 1 (Yao et al., 2018, Joyce et al., 2014a, Joyce et al., 2014b)).  
 
Further evidence for a close link between obesity, microbiota and circadian rhythms comes 
from the growing wealth of studies investigating the effects of intermittent fasting on 
metabolism and the gut microbiota (Li et al., 2017). Moreover, sleeve gastrectomy has also 
been shown to improve metabolism in animals fed a high-fat diet, which was mediated by 
change in the gut microbiota (Shao et al., 2018). Interestingly, oral administration of melatonin 
to mice fed a high-fat diet similarly resulted in an alleviation of weight gain and a change in the 
gut microbiota (Yin et al., 2018). The administration of the weight loss anti-angiogenic drug 
Fumagillin has also been shown to interact with both the microbiota and core circadian clock 
gene expression to elicit its metabolic effects (Table 2A (An et al., 2018)). It is worth noting that 
obesity can also be considered a brain disorder (Kure Liu et al., 2019, Liu et al., 2019a, 
Ziauddeen et al., 2012, Fletcher and Kenny, 2018), and there is a growing emphasis on the role 
of the microbiome-gut -brain axis in regulating central control of appetite, satiety, food choice, 
and obesity (Torres-Fuentes et al., 2017, Leitao-Goncalves et al., 2017, van de Wouw et al., 
2017). Nonetheless, the role of circadian rhythms in regulating this axis in obesity deserves 
much more attention. 
 
Diabetes 
Human and animal models with both types of diabetes (I and II) display differences in gut 
microbiota composition compared to their healthy counterparts (Table 2A (Wen et al., 2008, 
Kieler et al., 2019, Stenvers et al., 2019, Karlsson et al., 2013)). Specifically, individuals with type 
II diabetes exhibit reduced oscillation amplitude of core clock genes and a general reduction in 
diurnally rhythmic genes in adipose tissue when compared to healthy controls (Stenvers et al., 
2019). Also, although type II diabetic mice exhibited similar feeding and activity behaviors to 
wild-type mice, their gut microbiota showed a loss of diurnal oscillations in the genera 
Akkermanisa, Bifidobacterium, Allobaculum and Oscillospira, and a phase shift in the 
oscillations of the genus Prevotella and the phyla Proteobacteria and Actinobacteria (Table 3B 
(Beli et al., 2019). Interestingly, mice with deletions of either Clock or Bmal1 have diminished 
glucose tolerance and insulin secretion, providing a link between circadian rhythm genes and 
diabetes (Marcheva et al., 2010).  
 
Cardiovascular Disease 
Much work has demonstrated the involvement of the gut microbiota in cardiovascular disease 
(Ma and Li, 2018, Jie et al., 2017), where a human cohort of patients with atherosclerosis 
demonstrated increased abundances of Enterobacteriaceae and Streptococcus spp. and 
expressed an increased inflammatory profile (Jie et al., 2017). Mouse models of cardiovascular 
disease recovered faster in a 24-hour light-dark cycle compared to the those on a disrupted 
circadian rhythm, and an exacerbated heart condition (Table 2A (Martino et al., 2007)). 
Furthermore, mice with a 22-hour circadian cycle (due to a point mutation in casein-kinase 1, a 
circadian cycle regulatory gene) exhibited severe heart defects leading to early death, which 
was rescued by placing the animals in a 22-hour light-dark cycle (Martino et al., 2008). In 
humans, short-duration circadian misalignment resulted in increased 24-hour blood pressure 
the presence of inflammatory markers in the blood of healthy adults (Morris et al., 2016). 
Interestingly, either high-fiber or high-SCFA diets have been shown to not only positively 
modulate the gut (these mice exhibited a decrease in their Bacteroidetes: Firmicutes), but these 
diets also protect against cardiovascular disease and increase circadian rhythm regulation by 
upregulating circadian genes (Table 2A (Marques et al., 2017)).  
 
Although studies examining the relationship between circadian rhythms and the microbiota-
gut-brain axis are to date often correlational and not causal, their interaction is clear, and most 
apparent within the context of metabolic diseases. Across the spectrum, the gut microbiota and 




Much research has examined the relationship between circadian rhythms and psychiatric 
disorders, including major depressive disorder (MDD)(Ma et al., 2019, Murray, 2007), 
schizophrenia (Karatsoreos, 2014, Oliver et al., 2012), bipolar disorder (Takaesu, 2018), and 
anxiety (Fares et al., 2015) (Table 2B). Circadian rhythm disturbances (phenotypes) such as shift 
work, possessing an evening chronotype, or a phase delay in circadian rhythm onset, have all 
been associated with an increased prevalence or severity of MDD, which can be rescued by 
selective serotonin reuptake inhibitors (Karatsoreos, 2014, Takaesu, 2018, Vadnie and McClung, 
2017, Fares et al., 2015, Bastiaanssen et al., 2020). Human subjects with MDD exhibit significant 
differences in their microbiota compared to healthy controls (Zheng et al., 2016, Aizawa et al., 
2016, Jiang et al., 2015, Valles-Colomer et al., 2019). Interestingly, the administration of 
antibiotics such as minocycline (Miyaoka et al., 2012, Zheng et al., 2015), prebiotics (Burokas et 
al., 2017), or probiotics (Bravo et al., 2011) all exhibit antidepressant-like effects in animal 
models (Table 2B). Germ-free mice, like antibiotic-treated mice, exhibit decreased depressive 
and anxiety-like behaviors in response to stress when compared to their wild-type counterparts 
(Zheng et al., 2016, Clarke et al., 2013). Both depression and anxiety-like phenotypes were 
transferrable via a fecal matter transplant from human to rodent, or from rodent to rodent 
(Kelly et al., 2016, Zheng et al., 2016, De Palma et al., 2017), indicating the importance of a gut 
microbiota in the manifestation of these symptoms. The anxiety-like phenotype was alleviated 
with the administration of either prebiotics (Burokas et al., 2017) probiotics (Bravo et al., 2011), 
or via a Clock mutation (Roybal et al., 2007). 
 
Similar to depression, a number of small studies in human subjects with bipolar disorder have 
also shown an altered gut microbiota compared to healthy controls (Evans et al., 2017, 
Dickerson et al., 2018). Moreover, probiotic administration alleviated symptoms and reduced 
rehospitalization rates post-mania in a specific cohort (Dickerson et al., 2018). Interestingly, 
Clock gene polymorphisms in humans are associated with an increased recurrence risk in 
bipolar disorder (Roybal et al., 2007, Benedetti et al., 2003), and a mutation in the Clock gene in 
mice resulted in an increase in mania-like behavior compared to wild-type mice (Roybal et al., 
2007, Benedetti et al., 2003). Mouse models of schizophrenia have an advanced-phase 
circadian cycle (melatonin releases earlier in the cycle than normal) and fragmentation of the 
cycle (Oliver et al., 2012). Studies have also found that a copy number variation in a human SCN 
gene is associated with a higher schizophrenia risk (Vacic et al., 2011). 
 
Much of the evidence linking psychiatric illness to circadian rhythm disturbances comes from 
studies utilizing the mood stabilizer lithium (Table 2B (Roybal et al., 2007)). Lithium also affects 
sleep, circadian rhythms, the microbiota and inflammation. It is known to inhibit glycogen 
synthase kinase 3 (GSK3), thus causing REV-ERB to degrade, activating the circadian feedback 
loop, and decreasing the pro-inflammatory effects of GSK-3 (Yin et al., 2006, Beurel and Jope, 
2014). Lithium also interacts with sleep therapy and chronotherapy to increase potential 
efficacy of treatment (Table 2B (Karatsoreos, 2014, Benedetti et al., 2014)). One study found 
that the combination of sleep deprivation, light therapy and lithium resulted in a rapid and 
drastic decrease in suicidal symptoms in treatment-resistant bipolar depression (Benedetti et 
al., 2014). When administered to rats, lithium significantly increased species richness and 
diversity in the gut microbiota (Cussotto et al., 2019).  
 
Whereas much research has been conducted on the effect of the microbiota-gut-brain axis, 
circadian rhythms, and their interplay in metabolic disorders, in comparison there is still a 
paucity of research on the interplay between the microbiota-gut-brain axis and circadian 
rhythms in psychiatric disorders. Although their independent effects on psychiatric disorders 
are apparent, more preclinical and clinical work needs to be done to examine how both systems 
may engage with one another to modulate psychiatric disorders, positively and negatively. 
 
Neurodegenerative Disease 
Elderly people with dementia or AD are known to exhibit “sundowning”, described as cognitive 
decline and increased confusion and agitation as the sun sets (Canevelli et al., 2016). These 
patients have lower melatonin levels, neurofibrillary tangle-induced damage to their SCN (in 
AD), and a dysregulated HPA axis (Canevelli et al., 2016). Mouse models of AD also exhibit a 
shortened period length (Canevelli et al., 2016, Oyegbami et al., 2017, Song et al., 2015), 
blunted Cry1/2 cycle in the medulla (Canevelli et al., 2016, Oyegbami et al., 2017, Song et al., 
2015), and altered expression of Bmal1 and Per2 (Canevelli et al., 2016, Oyegbami et al., 2017, 
Song et al., 2015). Humans with AD show increased abundance of pro-inflammatory 
Escherichia/Shigella and a decreased abundance of anti-inflammatory E. rectale compared to 
age-matched, healthy controls (Cattaneo et al., 2017). Furthermore, bacteria are capable of 
producing their own amyloid (for example, E. coli), which could cause an increase in 
proinflammatory markers and potentially initiate cross seeding of amyloid plaques (Cattaneo et 
al., 2017, Schwartz and Boles, 2013, Chapman et al., 2002, Kowalski and Mulak, 2019). Elderly 
individuals are also susceptible to Parkinson’s disease, the manifestation of which is preceded 
by idiopathic rapid eye movement (iREM) sleep behavior disorder (RBD) (Heintz-Buschart et al., 
2018). Interestingly, the gut microbiota of patients with RBD or Parkinson’s disease are very 
similar, and both are significantly different to the gut microbiota of healthy, control patients 
(Heintz-Buschart et al., 2018).  
 
Taken together, neurodegenerative diseases represent an exciting avenue of future research to 
study the interplay between the microbiota-gut-brain axis and circadian rhythms. The 
connection between Alzheimer’s disease, circadian rhythms, and the microbiota-gut-brain axis 
(Hill et al., 2014) provides strong evidence that more research in this area is needed at the 
preclinical and clinical stages. Moreover, understanding the relative contribution of microbiota 
changes to RBD and circadian dysfunction may offer novel insights into the pathophysiology of 
Parkinson’s Disease. 
Conclusions and Future Directions 
There is growing evidence supporting not only an interaction, but also bidirectional 
communication between circadian rhythms and the gut microbiota. However, it is clear that the 
precise underpinnings of the mechanisms involved are still unknown. Although the majority of 
the data supporting their interaction is transitive and through an intermediary, these nodes of 
incorporation of the two systems are powerful, grouping into metabolism, the endocrine 
system, and the immune system. Unfortunately, thus far research has mostly only examined 
the effect of either circadian rhythm or gut microbiota/microbiota-gut-brain axis 
independently, but not together. There is a similar state of affairs regarding disease models; the 
current understanding mostly deals with metabolic diseases, the correlative conclusions of 
which demonstrate the cumulative effect of circadian rhythm dysfunction and gut microbiota 
alteration. Strong data linking circadian rhythm and gut microbiota dysfunction lies with their 
interactions with psychiatric illness, and neurodegenerative disease. Here, there is a wealth of 
information examining diseases resulting from, or exacerbated by, interactions of the gut 
microbiota and circadian rhythm. Further, the examination into metabolic disorders is a crucial 
step in the right direction, and more work needs to be done to examine not only how both the 
microbiota-gut-brain axis and circadian rhythms influence disease, but also how they interplay 
with one another in the context of disease. 
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Figure 1. Depiction of circadian rhythms, the gut microbiota, and their interaction and effect 
on general physiology in a healthy individual  
  
(A) An individual with a healthy microbiota, and a normal 24-hour light/dark cycle, 
 
(B) Positive transcription factors, CLOCK (circadian locomotor output cycles kaput) and BMAL1 
(brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1) heterodimerize 
in the cytoplasm, and translocate to the nucleus (Scheiermann et al., 2013). Once there, they 
bind to the E-box promotor region to initiate transcription and translation of the genes Per1/2 
(period) and Cry1/2 (cryptochrome). PER1/2 and CRY1/2 then heterodimerize and initiate 
inhibitory feedback of CLOCK and BMAL1. As PER1/2 and CRY1/2 decrease due to CLOCK and 
BMAL1 repression, and as ubiquitin degrades the PER-CRY dimer, the cycle begins again. 
Additionally, the transcription factor REV-ERB suppresses BMAL1, and ROR (retinoic acid-related 
orphan receptor) activates BMAL1 (Scheiermann et al., 2013). 
 
Figure 2. Effect of disturbances to either the circadian rhythm or the gut microbiota on host 
physiology 
 
Potential physiological effects of either a compromised light/dark cycle due to shift work or jet 
lag, and/or an altered microbiota due to a high-fat diet, antibiotics or eating during the inactive 
phase. Such insults can cause loss of normal rhythmic SCN firing (Froy and Garaulet, 2018, Barclay 
et al., 2012), a loss in rhythmic gut epithelial gene transcription (Kuang et al., 2019), arrhythmic 
bacterial population fluctuations (Beli et al., 2019, Tahara et al., 2018, Paulose et al., 2016), 
leading to a reduction in luminal bioactive molecule translocation across the gut epithelium 
(Turroni et al., 2018, Rea et al., 2017, Garrido et al., 2013), and a potential reduction in 
enteroendocrine activity (Larraufie et al., 2018, Larraufie et al., 2017, Plovier and Cani, 2017, 
Steinert et al., 2017), and a concomitant increase in luminal cytokine production (Rudzki et al., 
2019, Hao et al., 2019, Hantsoo et al., 2019).  
 
 
Figure 3. Pre-clinical methods currently utilized to study circadian rhythms and the 
microbiome-gut-brain axis. 
 
Examples include the use of antibiotics to ablate the gut microbiota (Mukherji et al., 2013, Wang 
et al., 2017); altering diet to modulate type of food and caloric amount available to the host 
(Astafev et al., 2017, Leone et al., 2015); adjusting availability of food to the host animal (Wehrens 
et al., 2017); introducing a time phase-shift to perturb the circadian clocks (Tahara et al., 2018, 
Voigt et al., 2014); using congenital models of circadian circuit modulation (Voigt et al., 2016b, 
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